Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis.

José Juan Pereyra-RodriguezSara Alcantara-LunaJavier Domínguez-CruzManuel Galán-GutiérrezRicardo Ruiz Villaverde Samuel Vilar-PalomoJose-Carlos Armario-Hita

Published in: Life (Basel, Switzerland) (2021)

We have included molecules still in the development phase as well studies completed and presented at conferences and with data available in Trialsgov® but not published yet. Several molecules' development had included a small number of patients from 12 to 17 years of age, without being able to differentiate the results from the adult population. Other: Founding: None. PROSPERO database registration number CRD42021225793.

Keyphrases

small molecule
end stage renal disease
atopic dermatitis
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
emergency department
early onset
systematic review
big data
protein protein
drug induced
data analysis
meta analyses